STAT+: Pharmalittle: We’re reading about a Merck deal for an obesity pill, a departing FDA official, and more
Image Credit: STAT News

STAT+: Pharmalittle: We’re reading about a Merck deal for an obesity pill, a departing FDA official, and more

Watchdoq December 18, 2024
Merck signed a deal worth up to $2 billion with Hansoh Pharma to develop and sell the Chinese biotech's oral obesity drug

Read Full Article